Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Tenon Medical, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/04/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 08/04/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/28/2023 |
8-K
| Quarterly results |
| 07/25/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 07/21/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 06/16/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 06/07/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 05/24/2023 |
4
| Ferrari Richard (Director) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 91,300 shares
@ $1.62, valued at
$147.9k
|
|
| 05/24/2023 |
4
| Hochschuler Stephen (Director) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 6,207 shares
@ $1.62, valued at
$10.1k
|
|
| 05/24/2023 |
4
| FOSTER STEVEN M (CEO and President) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 72,477 shares
@ $1.62, valued at
$117.4k
Sold 27,791 shares
@ $1.26, valued at
$35k
|
|
| 05/24/2023 |
4
| HOWARD IVAN (Director) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 6,207 shares
@ $1.62, valued at
$10.1k
|
|
| 05/24/2023 |
4
| GINN RICHARD (Chief Technology Officer) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 150,308 shares
@ $1.62, valued at
$243.5k
Sold 64,990 shares
@ $1.26, valued at
$81.9k
|
|
| 05/24/2023 |
4
| Fischer Frank M (Director) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 6,207 shares
@ $1.62, valued at
$10.1k
|
|
| 05/24/2023 |
4
| VAN DICK STEVEN M (CFO) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 30,433 shares
@ $1.62, valued at
$49.3k
|
|
| 05/24/2023 |
4
| WEIGLE ROBERT K (Director) has filed a Form 4 on Tenon Medical, Inc.|
Txns:
| Exercised 6,207 shares
@ $1.62, valued at
$10.1k
|
|
| 05/19/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/18/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/09/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 03/10/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/09/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 02/09/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 10/11/2022 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...|
Docs:
|
"CONSULTING AGREEMENT between TENON MEDICAL, INC. and SPINESOURCE, INC. This Consulting Agreement is entered into among and between Tenon Medical, Inc., a Delaware corporation having a place of business at 104 Cooper Court, Los Gatos, CA 95032 , and SpineSource, Inc., a Missouri corporation having a place of business at 17826 Edison Avenue, Chesterfield, MO 63005 . This Agreement shall become effective on the last date on which the Agreement is signed by all Parties . WHEREAS, Company and SpineSource previously entered into an “Exclusive Sales Representative Agreement,” dated April 27, 2020, as amended on December 15, 2020 , and an Amended and Restated Exclusive Sales Representative Agreement , dated May 20, 2021 , under which SpineSource received exclusive rights to market, promote and dis...",
"AGREEMENT TERMINATING AMENDED AND RESTATED EXCLUSIVE SALES REPRESENTATIVE AGREEMENT",
"Tenon Medical Accelerates Commercial Scale with Own Infrastructure to Support Top Line Growth, Terminates National Distribution Agreement for Company’ s Catamaran™ SI Joint Fusion System" |
|
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/27/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"SETTLEMENT AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS This Settlement Agreement and General Release of All Claims memorializes the settlement made by and between Key Medical Technologies, Inc. and Khalid Mentak on the one hand and Tenon Medical, Inc. on the other hand. Key Medical, Claimant, and Tenon are collectively referred to as “the Parties”. RECITALS WHEREAS, the consulting and/or employment relationship between Tenon and Claimant ended on or about June 1, 2021; WHEREAS, Claimant filed a claim for arbitration with the American Arbitration Association on or about September 2, 2021, alleging breach of contract and other claims, which was assigned AAA Case No. 01-21-0016-3950 ; WHEREAS, Tenon denied all of Claimant’ s claims against Tenon in the Action and asserted its own counter-clai..." |
|
| 06/09/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 06/07/2022 |
8-K
| Quarterly results |
| 05/31/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
SC 13G
| Zuhlke Ventures AG reports a 21.8% stake in Tenon Medical, Inc. |
| 05/16/2022 |
4
| WEIGLE ROBERT K (Director) has filed a Form 4 on Tenon Medical, Inc. |
|
|
|